CAPTOR THERAPEUTICS SPOLKA AKCYJNA

Highlights Captor Therapeutics Spolka Akcyjna

Equities

CTX

PLCPTRT00014

Delayed Warsaw S.E. Other stock markets 02:57:16 14/05/2024 pm IST			5-day change	1st Jan Change
77.6 ^PLN	+0.78%		-6.28%	-21.62%

2023	Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Nine Months Ended September 30, 2023	28/11	CI
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2023	07/23/07	CI
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023	29/23/29	CI
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022	07/23/07	CI
Captor Therapeutics Announces Three-Year Strategic Objectives	07/23/07	AQ
Captor Therapeutics Reports Q3 2022 Results and Provides Business UpdateLead assets approaching the clinic and new significant drug discovery collaboration signed with Ono Pharmaceutical	28/22/28	AQ
Captor Therapeutics Reports Q3 2022 Results and Provides Business Update	25/22/25	AQ
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/22/24	CI
Ono Pharmaceutical and Captor Therapeutics Announces Drug Discovery Collaboration to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases	14/22/14	CI
Captor Therapeutics S.A. Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma	10/22/10	CI
Captor Therapeutics S.A. Announces Molecular Targets of CT-01 Program Developing TPD Therapy for Hepatocellular Carcinoma	12/22/12	CI
Captor Therapeutics S.A. Presents Compelling in Vivo Proof-Of-Concept Data from CT-01 Program in Hepatocellular Carcinoma	13/22/13	CI
Captor Therapeutics Spolka Akcyjna has completed an IPO in the amount of PLN 183.954 million.	08/21/08	CI
Captor Therapeutics Spolka Akcyjna has filed an IPO.	22/21/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW